Manfidokimab - CAS 2428381-56-8

Manfidokimab (AK120) is a human monoclonal antibody of the IgG4 subclass that specifically targets the interleukin-4 receptor alpha subunit (IL-4Rα) . by binding to this shared subunit, Manfidokimab simultaneously blocks the downstream signaling pathways of both interleukin-4 (IL-4) and interleukin-13 (IL-13), and Manfidokimab can be used in studies about moderate to severe atopic dermatitis.

Interleukin, IL Receptor

Immunology/Inflammation

2428317

0.9741

-20°C

Ice Packs

Inhibitory Antibodies